loading page

PHARMACOKINETICS LIMITS CLINICAL USE OF IVERMECTIN FOR COVID-19
  • Ricardo Pena Silva,
  • Sandra Jaramillo Rincon
Ricardo Pena Silva
Universidad de los Andes
Author Profile
Sandra Jaramillo Rincon
Universidad de los Andes
Author Profile